1. CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML. (November 2018) Authors: Anderson, Elizabeth; Mehta, Priyanka; Heywood, Jonathan; Rees, Barbara; Bone, Heather; Robinson, Gareth; Reynolds, Darren; Salisbury, Vyv; Mayer, Lawrence Journal: Leukemia research Issue: Volume 74(2018) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations. (23rd December 2010) Authors: Zisman, Natalia; Dos Santos, Nancy; Johnstone, Sharon; Tsang, Alan; Bermudes, David; Mayer, Lawrence; Tardi, Paul Other Names: Peters G. J. Academic Editor. Journal: Chemotherapy research and practice Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes. (20th October 2016) Authors: Tardi, Paul; Wan, Chung Ping Leon; Mayer, Lawrence Journal: Journal of drug targeting Issue: Volume 24:Number 9(2016) Page Start: 797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tolerance and the Politics of Identity in the European Union1. (19th September 2013) Authors: Arwine, Alan; Mayer, Lawrence Journal: Social science quarterly Issue: Volume 95:Number 3(2014) Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗